Zhou, Feifan
Hainan University,
China
2025 Rank: 172812
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 893 out of 122662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 172812 | 183539 |
| Total Cites | 716 | 766 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 87 | 93 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 142 | 154 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 641 | 675 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
6.53%
|
|
Zhou, Feifan
Hainan University,
China
2024 Rank: 172826
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 987 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 172826 | 188783 |
| Total Cites | 678 | 739 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 84 | 86 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 112 | 116 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 613 | 656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
8.25%
|
|
Zhou, Feifan
Hainan University,
China
2023 Rank: 137039
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 788 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137039 | 145700 |
| Total Cites | 741 | 801 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 122 | 130 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 159 | 171 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 648 | 686 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
7.49%
|
|
Zhou, Feifan
Hainan University,
China
2022 Rank: 142211
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 881 out of 105572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142211 | 142132 |
| Total Cites | 554 | 612 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 142 | 159 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 160 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 471 | 489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.25 |
| Self-Citation Percentage |
9.48%
|
|
Zhou, Feifan
Shenzhen University,
China
2021 Rank: 196722
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1319 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 196722 | 209039 |
| Total Cites | 690 | 741 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 167 | 186 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 186 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 576 | 595 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.25 |
| Self-Citation Percentage |
6.88%
|
|
Zhou, Feifan
Shenzhen University,
China
2020 Rank: 229124
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Optics
Rank in SubField 1: 1618 out of 84246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 229124 | 214122 |
| Total Cites | 412 | 471 |
| H-index | 11 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 123 | 156 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 131 | 164 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 350 | 370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.27 |
| Self-Citation Percentage |
12.53%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.